News - Puma Biotech


Current filters:

Puma Biotech

Popular Filters

Puma Biotech rockets on positive results with neratinib in I-SPY 2 TRIAL


USA-based development-stage firm Puma Biotechnology saw its shares leap 42% to nearly $66 in morning…

BiotechnologyneratinibOncologyPfizerPuma BiotechResearch

Pfizer out-licenses neratinib to Puma Biotech; stops Lyrica epilepsy trial on good efficacy


In a second drug candidate sale this week, pharma behemoth Pfizer (NYSE: PFE) has agreed to sell rights…

FinancialLicensingLyricaNeurologicalOncologyPfizerPharmaceuticalPuma BiotechResearch

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top